Sample Page

5 Articles

Daniel Holmander and Jeffrey Techentin Named 2026 IP Stars by Managing IP

Posted August 5, 2026

Daniel J. Holmander and Jeffrey K. Techentin have once again been recognized as IP Stars by Managing IP, one of the legal industry’s leading guides to intellectual property practitioners. Dan was recognized as a Patent Star, while Jeff was named both a Patent Star and Trademark Star, reflecting their exceptional… Continue Reading

Leslie D. Parker Quoted in Rhode Island Lawyers Weekly on Health Care Fraud Enforcement

Posted August 4, 2026

Leslie D. Parker was recently quoted in Rhode Island Lawyers Weekly in its article, “Defense Lawyers in Demand Amidst Health Care Fraud Crackdown,” discussing the growing enforcement efforts targeting health care providers. The article examines how the U.S. Department of Justice is expanding its use of artificial intelligence and advanced… Continue Reading

Nicole J. Benjamin Quoted in Massachusetts Lawyers Weekly on the Impact of AI in Litigation

Posted August 4, 2026

Nicole J. Benjamin was recently featured in Massachusetts Lawyers Weekly discussing the evolving role of artificial intelligence in litigation practice. The article explores how artificial intelligence is transforming litigation, from legal research and document review to drafting pleadings and managing discovery, while also examining the ethical and practical considerations that… Continue Reading

Christian Capizzo Elected Vice Chair of Environmental Business Council’s Rhode Island Chapter

Posted August 3, 2026

AP&S is pleased to announce that Christian F. Capizzo, Senior Counsel at the firm, has been appointed Vice Chair of the Environmental Business Council (EBC) Rhode Island Chapter. As Vice Chair, Christian will work closely with the Chapter Chair and Leadership Team to help shape the chapter’s programming, identify timely… Continue Reading

Adler Pollock & Sheehan Congratulates Client Sernova Biotherapeutics on FDA Orphan Drug Designation

Posted June 22, 2026

Adler Pollock & Sheehan P.C. (“AP&S”) is pleased to congratulate its client, Sernova Biotherapeutics Inc. on the U.S. Food and Drug Administration’s (FDA) grant of Orphan Drug Designation for autologous islet transplantation (AIT) for the prevention of diabetes resulting from total pancreatectomy. The designation marks an important milestone in the… Continue Reading